General Information
Revision date
2009-10-01
Product name
FarmaLinx Atrazine 900 Herbicide
Substance name
Atrazine is a 1,3,5-triazine derivative
CAS No.
1912-24-9
Icons in SDS
Company Information
company name
FARMALINX Pty Ltd
Section 2
Hazard statements
This product is classified as: Xi, Irritating. T, Toxic. N, Dangerous to the environment. Hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. R43, R48/22, R50/53. May cause sensitisation by skin contact. Harmful danger of serious damage to health by prolonged exposure if swallowed. Very toxic to aquatic organisms, may cause long-term adverse effects to the aquatic environment.
Precautionary statements
S2, S22, S28, S46, S60, S61, S24/25, S36/37. Keep out of reach of children. Do not breathe dust After contact with skin, wash immediately with plenty of soap and water. If swallowed, contact a doctor or Poisons Information Centre immediately and show this MSDS or label. This material and its container must be disposed of as hazardous waste. Avoid release to the environment. Refer to special instructions/Safety Data Sheets. Avoid contact with skin and eyes. Wear suitable protective clothing and gloves.
SUSDP Classification
S5
ADG classification
None allocated. Not a Dangerous Good under the ADG Code
UN Number
None allocated Emergency Overview Physical Description & Colour: White granulated solid. Odour: No data.
Health hazards
Atrazine may be harmful to humans and to animals. It can be absorbed orally, dermally, and by inhalation. Symptoms of poisoning include abdominal pain, diarrhoea and vomiting, eye irritation, irritation of mucous membranes, and skin reactions. possible skin sensitiser.
Potential health effects
Inhalation: Short Term Exposure: Long term inhalation of high amounts of any nuisance dust may overload lung clearance mechanism. Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term Exposure: This product is carcinogenic by inhalation exposure. Skin Contact: Short Term Exposure: Classified as a potential sensitiser by skin contact. Exposure to a skin sensitiser, once sensitisation has occurred, may manifest itself as skin rash or inflammation, and in some individuals this reaction can be severe. In addition product may be irritating, but is unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: Available data shows that this product is not harmful. This product may be irritating to eyes, but is unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product may be irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: Atrazine is Class 3 - unclassifiable as to carcinogenicity to humans. See the IARC website for further details. A web address has not been provided as addresses frequently change.